| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 异新藤黄酸; Isogambogenic acid | CFN92096 | 887923-47-9 | C38H46O8 = 630.8 | 5mg | QQ客服：1413575084 |
| 新藤黄酸; Gambogenic acid | CFN92097 | 173932-75-7 | C38H46O8 = 630.8 | 20mg | QQ客服：215959384 |
| 表藤黄酸; Epigambogic acid | CFN92098 | 887606-04-4 | C38H44O8 = 628.8 | 10mg | QQ客服：1457312923 |
| 9R-10alpha-羟基表藤黄酸; 9R-10alpha-Hydroxyepigambogic acid | CFN92099 | 1097882-33-1 | C38H46O9 = 646.8 | 5mg | QQ客服：1457312923 |
| 10alpha-羟基表藤黄酸; 10alpha-Hydroxyepigambogic acid | CFN92100 | 1164201-85-7 | C38H46O9 = 646.8 | 5mg | QQ客服：2056216494 |
| 30-羟基藤黄酸; 30-Hydroxygambogic acid | CFN92101 | 881027-36-7 | C38H44O9 = 644.8 | 5mg | QQ客服：215959384 |
| 党参炔醇; Lobetyol | CFN92356 | 136171-87-4 | C14H18O3 = 234.3 | 5mg | QQ客服：215959384 |
| Lobetyolinin; Lobetyolinin | CFN92357 | 142451-48-7 | C26H38O13 = 558.6 | 10mg | QQ客服：1457312923 |
| Phellolactone; Phellolactone | CFN92554 | 1190897-23-4 | C13H14O8 = 298.3 | 5mg | QQ客服：1413575084 |
| 2-溴乙酰基噻吩; 2-Bromo-1-(3-thienyl)-1-ethanone | CFN90515 | 1468-82-2 | C6H5BrOS = 205.07 | 5mg | QQ客服：3257982914 |
| 律草酮; Humulone | CFN90541 | 26472-41-3 | C21H30O5 = 362.45 | 5mg | QQ客服：3257982914 |
| 6-甲基-5,6-二氢-2H-吡喃-2-酮; 6-Methyl-5,6-dihydropyran-2-one | CFN92589 | 108-54-3 | C6H8O2 = 112.1 | 5mg | QQ客服：3257982914 |
| 广藿香酮; Pogostone | CFN90555 | 23800-56-8 | C12H16O4 = 224.26 | 20mg | QQ客服：215959384 |
| Officinaruminane B; Officinaruminane B | CFN92687 | 1246282-67-6 | C29H36O = 400.6 | 5mg | QQ客服：1413575084 |
| Eurycomalin A; Eurycomalin A | CFN92749 | 790234-20-7 | C24H22O6 = 406.4 | 5mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)